Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.6B |
| 2 |
American Express
AXP
|
+$398M |
| 3 |
Capital One
COF
|
+$151M |
| 4 |
Apollo Global Management
APO
|
+$111M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$109M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
Amazon
AMZN
|
+$403M |
| 4 |
NVIDIA
NVDA
|
+$356M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$283M |
Sector Composition
| 1 | Technology | 30.21% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.22% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Photronics
PLAB
$1.33B
| $3.51M | ﹤0.01% |
136,000
+2,800
| +2% | +$72.2K |
|
1527
Comstock Resources
CRK
$4.67B
| $3.5M | ﹤0.01% |
302,100
+100,200
| +50% | +$1.16M |
|
1528
Delek US
DK
$1.68B
| $3.49M | ﹤0.01% |
145,791
+10,400
| +8% | +$249K |
|
1529
Bankunited
BKU
$2.96B
| $3.49M | ﹤0.01% |
162,000
-4,800
| -3% | -$103K |
|
1530
Luminar Technologies
LAZR
$129M
| $3.47M | ﹤0.01% |
33,580
+3,000
| +10% | +$310K |
|
1531
Virtu Financial
VIRT
$3.1B
| $3.46M | ﹤0.01% |
202,500
+19,400
| +11% | +$332K |
|
1532
Zentalis Pharmaceuticals
ZNTL
$107M
| $3.46M | ﹤0.01% |
122,600
+24,100
| +24% | +$680K |
|
1533
Strategic Education
STRA
$1.98B
| $3.46M | ﹤0.01% |
50,938
+800
| +2% | +$54.3K |
|
1534
Hanesbrands
HBI
$2.2B
| $3.45M | ﹤0.01% |
760,900
+7,800
| +1% | +$35.4K |
|
1535
Hudbay
HBM
$5.35B
| $3.45M | ﹤0.01% |
719,400
+234,600
| +48% | +$1.13M |
|
1536
Tandem Diabetes Care
TNDM
$829M
| $3.45M | ﹤0.01% |
140,600
+1,900
| +1% | +$46.6K |
|
1537
Kennedy-Wilson Holdings
KW
$1.24B
| $3.43M | ﹤0.01% |
210,268
-57,400
| -21% | -$937K |
|
1538
First Majestic Silver
AG
$5.15B
| $3.43M | ﹤0.01% |
605,200
+89,800
| +17% | +$508K |
|
1539
Bread Financial
BFH
$2.95B
| $3.43M | ﹤0.01% |
109,123
+1,500
| +1% | +$47.1K |
|
1540
Phreesia
PHR
$1.45B
| $3.42M | ﹤0.01% |
110,300
+2,600
| +2% | +$80.6K |
|
1541
Green Brick Partners
GRBK
$3.21B
| $3.42M | ﹤0.01% |
60,200
-4,400
| -7% | -$250K |
|
1542
Ameresco
AMRC
$1.44B
| $3.42M | ﹤0.01% |
70,300
+700
| +1% | +$34K |
|
1543
Talos Energy
TALO
$1.68B
| $3.41M | ﹤0.01% |
246,100
+121,300
| +97% | +$1.68M |
|
1544
Cohen & Steers
CNS
$3.65B
| $3.41M | ﹤0.01% |
58,800
+1,000
| +2% | +$58K |
|
|
VSTO
1545
DELISTED
Vista Outdoor Inc.
VSTO
| $3.41M | ﹤0.01% |
123,200
+1,100
| +0.9% | +$30.4K |
|
1546
Agios Pharmaceuticals
AGIO
$2.14B
| $3.41M | ﹤0.01% |
120,360
+13,700
| +13% | +$388K |
|
1547
Atlanta Braves Holdings Series B
BATRK
$2.64B
| $3.41M | ﹤0.01% |
86,029
+800
| +0.9% | +$31.7K |
|
1548
TPG
TPG
$9.05B
| $3.4M | ﹤0.01% |
116,300
+32,100
| +38% | +$939K |
|
1549
Asana
ASAN
$3.12B
| $3.4M | ﹤0.01% |
154,300
+3,200
| +2% | +$70.5K |
|
1550
InvenTrust Properties
IVT
$2.33B
| $3.4M | ﹤0.01% |
146,900
+1,300
| +0.9% | +$30.1K |
|